| 1 |
Cerebrolysin in the treatment of cognitive impairment |
|
| | A.N. Bogolepova | | | Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2023; 123(3): 20 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Knowledge, Attitudes and Practice of Healthcare Providers, Healthcare Regulatory Practitioners and Patients Toward Biosimilars in China: Insights From a Nationwide Survey |
|
| | Yang Hu, Zaiwei Song, Dan Jiang, Lin Zhuo, Yinchu Cheng, Rongsheng Zhao | | | Frontiers in Pharmacology. 2022; 13 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Clinical and Regulatory Concerns of Biosimilars: A Review of Literature |
|
| | Vesa Halimi, Armond Daci, Katerina Ancevska Netkovska, Ljubica Suturkova, Zaheer-Ud-Din Babar, Aleksandra Grozdanova | | | International Journal of Environmental Research and Public Health. 2020; 17(16): 5800 | | | [Pubmed] [Google Scholar] [DOI] | |
|
